Article

Prevention and therapy of SARS-CoV-2 and the B.1.351 variant in mice

2021-01-28

Abstract excerpt

<h4>SUMMARY</h4> Improving the standard of clinical care for individuals infected with SARS-CoV-2 variants is a global health priority. Small molecule antivirals like remdesivir (RDV) and biologics such as human monoclonal antibodies (mAb) have demonstrated therapeutic efficacy against SARS-CoV-2, the causative agent of COVID-19. However, it is not known if combination RDV/mAb will improve outcomes over single ag...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 51b8d85c-3856-5f5e-a75a-23ba05bd44c3
DOI: 10.1101/2021.01.27.428478

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Prevention and therapy of SARS-CoV-2 and the B.1.351 variant in miceDOI 10.1101/2021.01.27.428478Read

Murine monoclonal antibodies against RBD of SARS-CoV-2 neutralize authentic wild type SARS-CoV-2 as well as B.1.1.7 and B.1.351 viruses and protect <i>in vivo</i> in a mouse model in a neutralization dependent mannerSemantic proximity Read

A SCID mouse model to evaluate the efficacy of antivirals against SARS-CoV-2 infectionSemantic proximity Read

Mouse Antibodies with Activity Against the SARS-CoV-2 D614G and B.1.351 VariantsSemantic proximity Read

Murine Monoclonal Antibodies against the Receptor Binding Domain of SARS-CoV-2 Neutralize Authentic Wild-Type SARS-CoV-2 as Well as B.1.1.7 and B.1.351 Viruses and Protect In Vivo in a Mouse Model in a Neutralization-Dependent MannerSemantic proximity Read

Infection of wild-type mice by SARS-CoV-2 B.1.351 variant indicates a possible novel cross-species transmission routeSemantic proximity Read

Intranasal administration of a monoclonal neutralizing antibody protects mice against SARS-CoV-2 infectionSemantic proximity Read

Animal models for SARS-Cov2/Covid19 research-A commentarySemantic proximity Read

Toll-Like Receptor Agonist R848 Protects Mice from Lethal SARS-CoV-2 InfectionsSemantic proximity Read

An antibody from single human V H -rearranging mouse neutralizes all SARS-CoV-2 variants through BA.5 by inhibiting membrane fusionSemantic proximity Read

Potent neutralizing anti-SARS-CoV-2 human antibodies cure infection with SARS-CoV-2 variants in hamster modelSemantic proximity Read

Characterization of Three Variants of SARS-CoV-2 <i>in vivo</i> Shows Host-Dependent Pathogenicity in HamstersSemantic proximity Read

Characterization of SARS-CoV-2 Spike mutations important for infection of mice and escape from human immune sera.Semantic proximity Read